Vitamin markets: Vit D3 500 prices firmer, while A and E stable at high level
No new developments were really shared about vitamin E and A during the EuroTier exhibition. Suppliers remain keen to keep prices firm or even increase them further and buyers are waiting as long as they can with buying new material. Hence, not too much is happening at the moment in terms of price movement and/or actual transactions. Learn more in this week’s feed additives snapshot (week 47).
Cholin Chlorid from China will be investigated for potential anti-dumping into Europe. The EU commission has started an official investigation, just like with lysine. A few weeks ago, vitamin D3 showed some relief, but that was short-lived. Prices have increased again slightly and several Chinese suppliers have increased their price offers significantly. Availability is not ideal. Vitamin B3 has gone quiet as the product has been well contracted ahead. D-calpan manufacturers have a relatively strong desire to increase prices, but there is ample supply. Buyers are more active now in terms of considering taking longer forward cover. Other vitamins show little change compared to previous weeks.
In partnership with Feed Additive Prices
Vitamin E 50%
No specific news and/or updates were released during the EuroTier exhibition in Germany last week. There is an ongoing trend of buyers that continue to wait and see and suppliers that have a strong desire to maintain current market prices. This has so far resulted in mostly stable prices in all regions, although stable at a high level. No short-term changes are expected to these dynamics. Right now the market is relatively quiet and contracted for Q4 and a good portion of Q1.
Vitamin A 1000
Also for vitamin A1000, no specific news or updates were seen at the EuroTier exhibition. Prices are mostly stable but at a high price level. Manufacturers and suppliers are keen to hold up these high prices. Buyers have a strong wait-and-see attitude and can still carry on with their current contracts into early Q1. New suppliers from China are becoming more visible now and new capacity can be expected in 2025. Buyers have already secured most of their Q4 and some Q1 needs.
Vitamin D3 500
Only recently there seemed to be some relief in the D3 market, but that has changed back to a tight market again. Several manufacturers announced significant price increases and nearby availability in the regions seems to be tight after all. This has led to firmer prices and some new activity was seen. Most buyers are contracted ahead but will have to return to the market late Q4 again, in case they do not cover anything right now for Q1. Q4 is mostly contracted and a small portion of Q1 as well. But in general, the market is in a wait-and-see mode, despite the currently firmer market.
Vitamin B2 80%
Prices in Europe remain firmer compared to earlier this year, as there are no Chinese sources available, and Western sources indicate to have limited material available. By now most of Q4 has been contracted and a good portion of Q1 as well.
D-Calpan
Recently, several suppliers tried to increase prices, but so far they have not managed to get the market moving. Prices remain stable at a relatively low level and that goes for all regions. As there is an oversupply situation for this product, no signs of nearby change are expected. Q4 is mostly contracted and a good portion of Q1 is as well.
Vitamin B3
The vitamin B3 market has gone relatively quiet. After the recent price increase, buyers have secured their Q4 and partially Q1 needs and after that, the market has gone quiet. Contract execution and availability seem to be okay. Suppliers still have a relatively strong desire to increase prices further in the near future.
Biotin
No signs of any sort of change in the biotin market are seen or reported. Very static market at the moment. New additional production capacity in China has recently been announced for 2025. Q4 and a good portion of Q1 are contracted.
Vitamin C 35% mono
After some activity in the past few weeks and some firmer pricing, the market has become quiet again. Suppliers continue to insist on higher prices, therefore the current price level seems to be sticking. Q4 and a portion of Q1 have been contracted.
